Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma

Carcinogenesis

Volumn 32, Issue 11, 2011, Pages 1706-1712

  Morita, Shuko ^a   Matsumoto, Yuko ^a   Okuyama, Shunsuke ^a   Ono, Koh ^a   Kitamura, Yoko ^b   Tomori, Akihisa ^b   Oyama, Tsuneo ^b   Amano, Yuji ^c   Kinoshita, Yoshikazu ^c   Chiba, Tsutomu ^a   Marusawa, Hiroyuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Nagano Prefectural Federation of Agricultural Cooperative for Health and Welfare   (Japan)

^c SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; BILE ACID; DEOXYCHOLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GENE MUTATION; GENOTOXICITY; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; SQUAMOUS EPITHELIUM; TP53 GENE; TUMOR SUPPRESSOR GENE; VALIDATION STUDY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BILE ACIDS AND SALTS; BLOTTING, WESTERN; CELLS, CULTURED; CYTIDINE DEAMINASE; DEOXYCHOLIC ACID; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 80755187821     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr194     Document Type: Article

References (48)

1. Balkwill, F. et al. (2001) Inflammation and cancer: back to Virchow? Lancet, 357, 539-545.
2. Grivennikov, S.I. et al. (2010) Immunity, inflammation, and cancer. Cell, 140, 883-899.
3. Mantovani, A. et al. (2008) Cancer-related inflammation. Nature, 454, 436-444.
4. Thibodeau, S.N. et al. (1993) Microsatellite instability in cancer of the proximal colon. Science, 260, 816-819.
5. Colotta, F. et al. (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, 30, 1073-1081.
6. Kou, T. et al. (2007) Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Int. J. Cancer, 120, 469-476.
7. Matsumoto, Y. et al. (2007) Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat. Med., 13, 470-476.
8. Harris, R.S. et al. (2002) RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell, 10, 1247-1253.
9. Harris, R.S. et al. (2004) Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol., 4, 868-877.
10. Honjo, T. et al. (2002) Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol., 20, 165-196.
11. Revy, P. et al. (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell, 102, 565-575.
12. Muramatsu, M. et al. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell, 102, 553-563.
13. Okazaki, I.M. et al. (2003) Constitutive expression of AID leads to tumorigenesis. J. Exp. Med., 197, 1173-1181.
14. Morisawa, T. et al. (2008) Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression. Int. J. Cancer, 123, 2735-2740.
15. Endo, Y. et al. (2008) Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology, 135, e881-e883.
16. Endo, Y. et al. (2007) Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling. Oncogene, 26, 5587-5595.
17. Komori, J. et al. (2008) Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. Hepatology, 47, 888-896.
18. Marusawa, H. (2008) Aberrant AID expression and human cancer development. Int. J. Biochem. Cell Biol., 40, 1399-1402.
19. Kinoshita, K. et al. (2006) The dark side of activation-induced cytidine deaminase: relationship with leukemia and beyond. Int. J. Hematol., 83, 201-207.
20. Reid, B.J. et al. (2010) Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat. Rev. Cancer, 10, 87-101.
21. Shaheen, N.J. et al. (2009) Barrett's oesophagus. Lancet, 373, 850-861.
22. Nehra, D. et al. (1999) Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut, 44, 598-602.
23. Zhang, F. et al. (2001) Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology, 121, 1391-1399.
24. Flejou, J.F. (2005) Barrett's oesophagus: from metaplasia to dysplasia and cancer. Gut, 1, i6-i12.
25. Barrett, M.T. et al. (1999) Evolution of neoplastic cell lineages in Barrett oesophagus. Nat. Genet., 22, 106-109.
26. Marusawa, H. et al. (2010) Helicobacter pylori-induced activation-induced cytidine deaminase expression and carcinogenesis. Curr. Opin. Immunol., 22, 442-447.
27. Sampliner, R.E. (2002) Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am. J. Gastroenterol., 97, 1888-1895.
28. Ta, V.T. et al. (2003) AID mutant analyses indicate requirement for classswitch-specific cofactors. Nat. Immunol., 4, 843-848.
29. Horie, T. et al. (2010) MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc. Natl Acad. Sci. USA, 107, 17321-17326.
30. Miwa, K. et al. (1996) Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int. J. Cancer, 67, 269-274.
31. Jenkins, G.J. et al. (2004) The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis, 25, 317-323.
32. Debruyne, P.R. et al. (2006) Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells. Gastroenterology, 130, 1191-1206.
33. Payne, C.M. et al. (2007) Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis, 28, 215-222.
34. Wu, J. et al. (2008) Deoxycholic acid induces the overexpression of intestinal mucin, MUC2, via NF-kB signaling pathway in human esophageal adenocarcinoma cells. BMC Cancer, 8, 333.
35. Cronin, J. et al. (2010) The role of secondary bile acids in neoplastic development in the oesophagus. Biochem. Soc. Trans., 38, 337-342.
36. Matsumoto, Y. et al. (2010) Upregulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b-CDKN2a in gastric cancer. Gastroenterology, 139, 1984-1994.
37. Maley, C.C. (2007) Multistage carcinogenesis in Barrett's esophagus. Cancer Lett., 245, 22-32.
38. Paulson, T.G. et al. (2008) p.16 mutation spectrum in the premalignant condition Barrett's esophagus. PLoS One, 3, e3809.
39. Fitzgerald, R.C. (2006) Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut, 55, 1810-1820.
40. Gillen, P. et al. (1988) Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus. Br. J. Surg., 75, 540-543.
41. Nagengast, F.M. et al. (1995) Role of bile acids in colorectal carcinogenesis. Eur. J. Cancer, 31A, 1067-1070.
42. Tselepis, C. et al. (2003) Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut, 52, 174-180.
43. Looby, E. et al. (2009) Deoxycholate induces COX-2 expression via Erk1/2-, p.38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells. BMC Cancer, 9, 190.
44. Yen, C.J. et al. (2008) Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Res., 68, 2632-2640.
45. Jenkins, G.J. et al. (2008) The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS. Mutagenesis, 23, 399-405.
46. Neshat, K. et al. (1994) p.53 mutations in 6 and high-grade dysplasia. Gastroenterology, 106, 1589-1595.
47. Leedham, S.J. et al. (2008) Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut, 57, 1041-1048.
48. Gutierrez-Gonzalez, L. et al. (2011) The clonal origins of dysplasia from intestinal metaplasia in the human stomach. Gastroenterology, 140, 1251-1260e1251-e1256.